Testing a new hepatitis A vaccine in healthy people
Treatments studied
Part of Digestive system clinical trials.
This trial tests a new hepatitis A vaccine in healthy people aged 1 year and older. It aims to see how well the vaccine prevents hepatitis A and checks for any side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 1 year old or older and in good health.
- You should not have had a hepatitis A vaccine or hepatitis A infection before.
- You should not have any known allergies to vaccine ingredients.
- You should not have autoimmune or immune deficiency diseases, or poorly controlled chronic conditions.
- Women who can become pregnant must agree to use contraception during the study and for 30 days after the second shot.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how well a single dose of the hepatitis A vaccine works in people with cirrhosis who have no prior immunity. It aims to see if the vaccine provides protection for this group.
This trial tests a new protein-based vaccine to prevent hepatitis C. It is for healthy, non-smoking adults aged 18-45 who are up to date on their flu and COVID-19 vaccines.
This study looks at how the immune system responds in children with acute hepatitis A (a liver infection). It hopes to learn more about immunity to help improve care for kids with this infection.
This trial tests a new treatment (GST-HG131&141 tablets) versus a placebo for people with chronic hepatitis B. It aims to see if the treatment can better control the virus in those already on stable therapy.
This trial tests a new way to give the hepatitis B vaccine using a patch applied to the skin, instead of a needle. It is for healthy adults aged 19 to 40 who have not already been vaccinated against hepatitis B.
This study is testing a new hepatitis B vaccine called SN2001 in healthy adults. It will check how safe the vaccine is, what dose works best, and how well it helps your body build protection against hepatitis B.
Hear when a new Hepatitis A Vaccine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.